World's Best Scientists 2026 revealed!

Overview

Paolo Peterlongo is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research primarily focuses on biochemistry, genetics, and molecular biology, with an emphasis on genetics, molecular biology, cancer research, oncology, and pathology and forensic medicine.

The scientist's work covers several important topics, including:

  • BRCA gene mutations in cancer
  • Genetic Associations and Epidemiology
  • Cancer Genomics and Diagnostics
  • Genetic factors in colorectal cancer
  • DNA Repair Mechanisms
  • Genomics and Rare Diseases
  • Nutrition, Genetics, and Disease

Paolo Peterlongo has published numerous academic papers, many of which appear in well-known venues. Their recent publications include:

  • Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes, 2022, JAMA Oncology
  • Breast cancer risks associated with missense variants in breast cancer susceptibility genes, 2022, Genome Medicine
  • Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants, 2021, Genetics in Medicine
  • The impact of coding germline variants on contralateral breast cancer risk and survival, 2023, The American Journal of Human Genetics
  • Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction, 2020, UNC Libraries

The scientist frequently publishes in journals such as bioRxiv (Cold Spring Harbor Laboratory), UNC Libraries, Cancers, Genetics in Medicine, and npj Breast Cancer.

Collaboration is a notable part of Paolo Peterlongo's academic activities. Frequent co-authors include:

  • Paolo Radice
  • Irene L. Andrulis
  • Anna Jakubowska
  • Georgia Chenevix-Trench
  • Thilo Dörk

Best Publications

  • Association analysis identifies 65 new breast cancer risk loci

    Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley

  • Large-scale genotyping identifies 41 new loci associated with breast cancer risk

    Kyriaki Michailidou;Per Hall;Anna Gonzalez-Neira;Maya Ghoussaini

  • Breast-Cancer Risk in Families with Mutations in PALB2

    A. C. Antoniou;S. Casadei;T. Heikkinen;D. Barrowdale

  • RAD51B in Familial Breast Cancer

    Liisa M. Pelttari;Sofia Khan;Mikko Vuorela;Johanna I. Kiiski

  • Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

    Nasim Mavaddat;Kyriaki Michailidou;Kyriaki Michailidou;Joe Dennis;Michael Lush

  • Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women

    Leila Dorling;Sara Carvalho;Jamie Allen

  • Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche

    John R.B. Perry;Felix Day;Cathy E. Elks;Patrick Sulem

  • Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

    Kyriaki Michailidou;Jonathan Beesley;Sara Lindstrom;Sander Canisius

  • Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

    Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley

  • Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

    Nasim Mavaddat;Paul D.P. Pharoah;Kyriaki Michailidou;Jonathan Tyrer

  • MicroRNA related polymorphisms and breast cancer risk

    Sofia Khan;Dario Greco;Dario Greco;Kyriaki Michailidou;Roger L. Milne;Roger L. Milne

  • Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair

    Felix R. Day;Katherine S. Ruth;Deborah J Thompson;Kathryn L. Lunetta

  • Genome-wide association studies identify four ER negative-specific breast cancer risk loci

    Montserrat Garcia-Closas;Fergus J. Couch;Sara Lindstrom;Kyriaki Michailidou

  • Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

    Catherine M Phelan;Karoline B Kuchenbaecker;Karoline B Kuchenbaecker;Jonathan P Tyrer;Siddhartha P Kar

  • A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population

    Antonis C. Antoniou;Xianshu Wang;Zachary S. Fredericksen;Lesley McGuffog

  • Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.

    Roger L Milne;Roger L Milne;Karoline B Kuchenbaecker;Karoline B Kuchenbaecker;Kyriaki Michailidou;Kyriaki Michailidou;Jonathan Beesley

  • Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

    Antonis C. Antoniou;Antonis C. Antoniou;Amanda B. Spurdle;Amanda B. Spurdle;Olga M. Sinilnikova;Olga M. Sinilnikova;Sue Healey;Sue Healey

  • Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

    Haoyu Zhang;Haoyu Zhang;Thomas U. Ahearn;Julie Lecarpentier;Daniel Barnes

  • Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

    Fergus J. Couch;Xianshu Wang;Lesley McGuffog;Andrew Lee

  • C-kit mutations in core binding factor leukemias.

    Alessandro Beghini;Paolo Peterlongo;Carla B. Ripamonti;Lidia Larizza

Frequent Co-Authors

Graham G. Giles
Graham G. Giles University of Melbourne
Irene L. Andrulis
Irene L. Andrulis University of Toronto
Paolo Radice
Paolo Radice Fondazione IRCCS Istituto Nazionale dei Tumori
Roger L. Milne
Roger L. Milne Cancer Council Victoria
Hiltrud Brauch
Hiltrud Brauch German Cancer Research Center
Melissa C. Southey
Melissa C. Southey Monash University
Peter A. Fasching
Peter A. Fasching University of Erlangen-Nuremberg
Georgia Chenevix-Trench
Georgia Chenevix-Trench QIMR Berghofer Medical Research Institute
Fergus J. Couch
Fergus J. Couch Mayo Clinic
Douglas F. Easton
Douglas F. Easton University of Cambridge

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring healthcare professions in the USA offers many avenues beyond traditional medical school. For those looking for alternative paths, there are easy nursing schools to get into, which can be a good choice for students seeking a quicker entry into patient care roles. Some options, such as LPN programs, may not require traditional entrance exams. Wondering do you have to take a teas test for lpn? Many nursing schools don’t require the TEAS or HESI exams, making the admissions process more accessible.

For those interested in the administrative side of healthcare, there are reputable healthcare administration programs available online, often in accelerated formats for faster degree completion. If direct medical care isn’t for you, medical billing and coding is another in-demand field. Numerous online medical billing and coding with financial aid options offer flexibility and support, making it possible to launch a healthcare career from home.

Best Scientists Citing Paolo Peterlongo

Trending Scientists

Recently Published Articles